Rein Therapeutics, Inc. (RNTX)

Nasdaq · Pharmaceutical Preparations

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Insider purchase
    Voss Value Master Fund, LP (ten_percent_owner) bought $127k of stock
  6. Insider purchase
    Voss Value-Oriented Special Situations Fund, LP (ten_percent_owner) bought $248k of stock
  7. Insider purchase
    Voss Value-Oriented Special Situations Fund, LP (ten_percent_owner) bought $127k of stock
  8. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-05-27VON RICKENBACH JOSEF HdirectorP4,5001.07$4,815
2026-05-26VON RICKENBACH JOSEF HdirectorP23,1901.06$24,581
2026-05-22VON RICKENBACH JOSEF HdirectorP15,9501.05$16,748
2026-05-21VON RICKENBACH JOSEF HdirectorP3,4201.04$3,557
2026-04-30WINDSOR JAMES BRIANdirectorP25,0001$25,000
2025-11-14Voss Value Master Fund, LPten percent ownerP104,1831.22$127,103
2025-10-28Voss Value-Oriented Special Situations Fund, LPten percent ownerP178,3921.39$247,965
2025-10-27Voss Value-Oriented Special Situations Fund, LPten percent ownerP92,6421.37$126,920
2025-10-27Voss Value-Oriented Special Situations Fund, LPten percent ownerP4,8401.37$6,631
2025-10-24Voss Value-Oriented Special Situations Fund, LPten percent ownerP30,1761.39$41,945
2024-12-05WINDSOR JAMES BRIANofficerP1612.25$362
2024-12-05WINDSOR JAMES BRIANofficerP2392.24$535

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings